Immuno-oncology Development Trends and Opportunities

Publisher Name :
Date: 01-Nov-2018
No. of pages: 258

Immuno-oncology Development Trends and Opportunities

Summary

Immuno-oncology (IO) is the treatment of cancer with therapies that stimulate or suppress the body's own immune system. Several distinct modalities of IO therapy exist, including bispecific T-cell engaging monoclonal antibodies, cellular immunotherapy and adoptive cellular therapy, cancer vaccines, checkpoint modulating monoclonal antibodies, and oncolytic viruses.

This report provides an overview of current clinical development trends for IO within the 8MM (France, Germany, Italy, Spain, UK, US, Japan, China), including a history of recent approvals, indications currently being explored for IO agents of all modalities, targets being selected for IO therapies, and combination strategies being investigated for approved IO agents. In addition, the report provides disease overviews, epidemiology, current recommended treatment regimens and IO approvals, and IO clinical trial trends for 17 indications which GlobalData has identified as representing the largest commercial opportunities for IO agents. Clinical trial trends analyze ongoing trials by sponsor type and modality, as well as ongoing combination trials for approved IO therapies.

Scope

This report combines primary research from a cross-specialty panel of oncology experts with in-house analyst expertise to provide an assessment of the development landscape. Components of the slide deck include primary and secondary research -

- Quotes from 13 US-, 5EU-, and Japan-based key opinion leaders

- Summary of IO product definitions and classifications

- Overview of development opportunities for IO agents across indications, including emerging indications and clinical targets, and novel combination strategies

- Outline of 17 key indications for IO agents, including current EU and US guideline recommendations, IO's current place in the treatment algorithm, and a review of ongoing clinical trials

- Call-outs of key information and details

- Insight from GlobalData's specialist oncology analysts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving IO in the 8MM.

- Drive revenues by understanding the key trends, innovative combination strategies and indications likely to impact the IO market in the future.

- Design your development strategy through a review of potential novel targets or combinations across indications.

- Organize your sales and marketing efforts by understanding IO combination approaches across indications that present maximum opportunities for consolidations, investments, and strategic partnerships.

- Develop strategies by understanding expert perceptions of unmet needs in key indications in oncology, and the potential for IO agents to meet those needs.

Immuno-oncology Development Trends and Opportunities

Table of Contents
1. Preface 2
1.1 Related Reports 6
1.2 Upcoming Reports 8
1.3 Abbreviations 9
2. Executive Summary 12
3. Introduction 17
3.1 Immuno-oncology Overview 18
3.2 IO Product Definition and Classification 19
3.3 Report Structure 20
3.4 Key Indications for IO Agents 21
4. Development Opportunities for IO Agents 23
4.1 Timeline of Recent IO Approvals in the 8MM 25
4.2 Clinical Development of IO Agents Across Indications 33
4.2.1 IO Agents in Development by MOA and by Indication 35
4.2.2 Ongoing Clinical Trials by Sponsor Type 38
4.2.3 Key and Emerging Indications for Checkpoint Modulators 42
4.2.4 Key and Emerging Indications for Bispecific Antibodies 47
4.2.5 Key and Emerging Indications for Cancer Vaccines 49
4.2.6 Key and Emerging Indications for Cell Therapies 53
4.2.7 Key and Emerging Indications for Oncolytic Viruses 56
4.3 Combinations of Approved IO Agents 59
4.4 Clinical Targets and Predictive Biomarkers for IO Agents 66
4.4.1 Clinical Targets for Checkpoint Modulators 68
4.4.2 Clinical Targets for Bispecific Antibodies 71
4.4.3 Clinical Targets for Cell Therapies 73
4.4.4 Predictive Biomarkers for IO Agents 77
5. Acute Lymphoblastic Leukemia (ALL) 78
5.1 Disease Overview and Epidemiology 80
5.2 Current Treatment Guidelines and IO Approvals for ALL 82
5.3 Clinical Trial Activity in ALL 83
5.4 IO Marketed Product Lifecycle Development in ALL 86
6. Bladder Cancer 89
6.1 Disease Overview and Epidemiology 91
6.2 Current Treatment Guidelines and IO Approvals for Bladder Cancer 93
6.3 Clinical Trial Activity in Bladder Cancer 94
6.4 IO Marketed Product Lifecycle Development in Bladder Cancer 97
7. Breast Cancer 100
7.1 Disease Overview and Epidemiology 102
7.2 Current Treatment Guidelines and IO Approvals for Breast Cancer 104
7.3 Clinical Trial Activity in Breast Cancer 105
8. Chronic Lymphocytic Leukemia (CLL) 108
8.1 Disease Overview and Epidemiology 110
8.2 Current Treatment Guidelines and IO Approvals for CLL 112
8.3 Clinical Trial Activity in CLL 113
9. Colorectal Cancer 116
9.1 Disease Overview and Epidemiology 118
9.2 Current Treatment Guidelines and IO Approvals for Colorectal Cancer 120
9.3 Clinical Trial Activity in Colorectal Cancer 121
9.4 IO Marketed Product Lifecycle Development in Colorectal Cancer 124
10. Gastric and Gastroesophageal Cancer (GA/GEJAC) 126
10.1 Disease Overview and Epidemiology 128
10.2 Current Treatment Guidelines and IO Approvals for GA/GEJAC 130
10.3 Clinical Trial Activity in GA/GEJAC 131
10.4 IO Marketed Product Lifecycle Development in GA/GEJAC 134
11. Glioblastoma 136
11.1 Disease Overview and Epidemiology 138
11.2 Current Treatment Guidelines and IO Approvals for Glioblastoma 140
11.3 Clinical Trial Activity in Glioblastoma 141
12. Head and Neck Cancer 144
12.1 Disease Overview and Epidemiology 146
12.2 Current Treatment Guidelines and IO Approvals for Head and Neck Cancer 148
12.3 Clinical Trial Activity in Head and Neck Cancer 149
12.4 IO Marketed Product Lifecycle Development in Head and Neck Cancer 152
13. Hepatocellular Carcinoma (HCC) 154
13.1 Disease Overview and Epidemiology 156
13.2 Current Treatment Guidelines and IO Approvals for HCC 158
13.3 Clinical Trial Activity in HCC 159
13.4 IO Marketed Product Lifecycle Development in HCC 162
14. Melanoma 164
14.1 Disease Overview and Epidemiology 166
14.2 Current Treatment Guidelines and IO Approvals for Melanoma 168
14.3 Clinical Trial Activity in Melanoma 169
14.4 IO Marketed Product Lifecycle Development in Melanoma 172
15. Multiple Myeloma 175
15.1 Disease Overview and Epidemiology 177
15.2 Current Treatment Guidelines and IO Approvals in Multiple Myeloma 179
15.3 Clinical Trial Activity in Multiple Myeloma 180
16. Non-Hodgkin Lymphoma (NHL) 183
16.1 Disease Overview and Epidemiology 185
16.2 Current Treatment Guidelines and IO Approvals for NHL 187
16.3 Clinical Trial Activity in NHL 188
16.4 IO Marketed Product Lifecycle Development in NHL 191
17. Non-Small Cell Lung Cancer (NSCLC) 193
17.1 Disease Overview and Epidemiology 195
17.2 Current Treatment Guidelines and IO Approvals for NSCLC 198
17.3 Clinical Trial Activity in NSCLC 199
17.4 IO Marketed Product Lifecycle Development in NSCLC 202
18. Ovarian Cancer 204
18.1 Disease Overview and Epidemiology 206
18.2 Current Treatment Guidelines and IO Approvals for Ovarian Cancer 208
18.3 Clinical Trial Activity in Ovarian Cancer 209
19. Pancreatic Cancer 212
19.1 Disease Overview and Epidemiology 214
19.2 Current Treatment Guidelines and IO Approvals for Pancreatic Cancer 216
19.3 Clinical Trial Activity in Pancreatic Cancer 217
20. Prostate Cancer 220
20.1 Disease Overview and Epidemiology 222
20.2 Current Treatment Guidelines and IO Approvals for Prostate Cancer 224
20.3 Clinical Trial Activity in Prostate Cancer 225
20.4 IO Marketed Product Lifecycle Development in Prostate Cancer 228
21. Renal Cell Carcinoma (RCC) 230
21.1 Disease Overview and Epidemiology 232
21.2 Current Treatment Guidelines and IO Approvals for RCC 234
21.3 Clinical Trial Activity in RCC 235
21.4 IO Marketed Product Lifecycle Development in Multiple Myeloma 238
22. Appendix 240
22.1 Methodology 241
22.2 Primary Research 245
22.3 Sources 247
22.4 About the Authors 254
22.5 About GlobalData 256
22.6 Contact Us 257
22.7 Disclaimer 258
  • Global Stem Cell Source Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 97
    The global Stem Cell Source market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Stem Cell Source volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Stem Cell Source market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: No......
  • Global Soft Tissue Fillers Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 91
    The global Soft Tissue Fillers market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Soft Tissue Fillers volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Soft Tissue Fillers market size by analysing historical data and future prospect. Regionally, this report focuses on several key re......
  • Global Herbal Oil Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 119
    The global Herbal Oil market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Herbal Oil volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Herbal Oil market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europ......
  • Global Weight Reduction Medicine Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 117
    The global Weight Reduction Medicine market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Weight Reduction Medicine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Weight Reduction Medicine market size by analysing historical data and future prospect. Regionally, this report focuses......
  • Global Oral Ulcer Drug Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 120
    The global Oral Ulcer Drug market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Oral Ulcer Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Oral Ulcer Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North......
  • Global Hemodialysis Blood Tubing Sets Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 99
    The global Hemodialysis Blood Tubing Sets market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Hemodialysis Blood Tubing Sets volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hemodialysis Blood Tubing Sets market size by analysing historical data and future prospect. Regionally, this......
  • Global Digestive System Drugs Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 91
    The global Digestive System Drugs market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Digestive System Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Digestive System Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on sever......
  • Global Endocrine System Drugs Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 93
    The global Endocrine System Drugs market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Endocrine System Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Endocrine System Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on sever......
  • Global Small Molecule Tyrosine Kinase Inhibitor Market Research Report 2020
    Published: 08-Apr-2020        Price: US 2900 Onwards        Pages: 90
    The global Small Molecule Tyrosine Kinase Inhibitor market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Small Molecule Tyrosine Kinase Inhibitor volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Small Molecule Tyrosine Kinase Inhibitor market size by analysing historical data and fut......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs